Diversified Medical Healthcare Acquires RapidRona

Rho Acquires Dokumeds

December 8, 2021

Healthcare Services

Rho, a privately held full-service contract research organization (CRO) based in Research Triangle Park/Durham, North Carolina, has acquired Dokumeds, a privately held European CRO headquartered in Riga, Latvia. The acquisition expands Rho's global footprint and clinical development capabilities, providing clients broader access to patients and multinational trial support; terms were not disclosed.

Ro Acquires Kit to Expand At-Home Diagnostics

June 30, 2021

Healthcare Services

Ro, the healthcare technology company, has acquired at-home diagnostics provider Kit to add self-administered testing products and a CLIA-certified lab to Ro's vertically integrated primary care platform. The acquisition expands Ro's in-home care and diagnostics capabilities and enables Kit's tests to be ordered directly through Ro's platform while Kit continues to serve existing B2B customers.

Diversified Medical Healthcare Acquires ConfirmD Mobile App from Buddycheque LLC

December 22, 2021

Healthcare Services

Diversified Medical Healthcare (DMH), a Greenville, South Carolina-based healthcare holding company, has acquired the ConfirmD mobile app and platform from Buddycheque LLC. ConfirmD is a HIPAA-compliant digital health wallet that helps employers track employee COVID-19 testing and vaccination status and integrates with lab systems to streamline compliance and reporting.

Uniphar plc Acquires RRD International

November 24, 2020

Healthcare Services

Uniphar plc, a Dublin-based diversified healthcare services group, has acquired RRD International, a US-based product development and regulatory consulting firm focused on early-stage biopharmaceutical development. The acquisition is intended to expand Uniphar's US Product Access capabilities—including Expanded Access Programs (EAPs)—and RRD will continue to operate autonomously while integrating with Uniphar's Product Access division.

R-Biopharm AG Acquires AusDiagnostics

June 7, 2022

Biotechnology

German biotechnology company R-Biopharm AG has acquired Australian molecular diagnostics manufacturer AusDiagnostics. The purchase adds AusDiagnostics' multiplex MT-PCR platforms, extraction reagents and laboratory automation capabilities to R-Biopharm's clinical diagnostics portfolio, supporting capability expansion and internationalization into new clinical, veterinary and applied testing markets.

RDi Acquires Inicio Health

April 8, 2025

Healthcare Services

LDC-backed RDi has acquired Inicio Health, a UK-based provider of digital interoperability, automation and AI solutions for healthcare. The deal integrates Inicio Health's platforms (including +Cura, inicioAutomate, inicioPages and inicioHub) with RDi's self-sampling and home testing capabilities to create an end-to-end digital diagnostics and screening pathway.